RIMAG GROUP (02522) has announced its interim results for the six months ended June 30, 2026, with revenue climbing to RMB 513 million, representing a year-on-year increase of 9.8%.
The company reported a loss attributable to shareholders of RMB 13.891 million, with a loss per share of RMB 0.036. The revenue uptick was primarily driven by the group's strategic focus on digital transformation within the industry, as it continued to build an intelligent medical imaging ecosystem.
This strategic direction enabled broader implementation of enabling solution services and digital intelligence services, fueling overall revenue growth. Specifically, the group leveraged its enabling solution services as a key growth engine, expanding into lower-tier markets and broadening its client base across public hospitals at various levels and primary healthcare facilities.
This deep-seated push to tap into recurring demand from existing medical institutions directly propelled sustained revenue increases in the enabling solutions segment. In parallel, significant strides were made across four core pillars—data governance, asset monetization, AI products, and ecosystem collaboration—leading to a breakthrough in digital intelligence services. Revenue from this segment surged more than threefold compared to the same period in 2025, accelerating the realization of its commercial value.
Comments